Publications

5891 Results

Concurrent carboplatin/etoposide and radiation followed by paclitaxel consolidation for poor risk stage III non-small cell lung cancer: a Southwest Oncology Group (SWOG) phase II trial (S9712)

Authors
A Davies;D Lau;J Crowley;B Leigh;DR Gandara
Journal / Conference
Proc of the American Society of Clinical Oncology 21:298a(#1191)
Year
2002
Research Committee(s)
Lung
Study Number(s)
S9712

Phase II (SWOG 9713) trial of cisplatin/etoposide (PE) and concurrent radiotherapy (XRT) followed by paclitaxel/carboplatin (TC) consolidation for limited small cell lung cancer (LSCLC)

Authors
MJ Edelman;K Chansky;B Leigh;J Crowley;DR Gandara
Journal / Conference
Proc of the American Society of Clinical Oncology 21:303a(#1210)
Year
2002
Research Committee(s)
Lung
Study Number(s)
S9713

Evaluation of vinorelbine tartrate (navelbine) in patients with dissemminated malignant melanoma and at least one prior systemic therapy, phase II: a Southwest Oncology Group Study

Authors
J Moon;RP Whitehead;S McCachren;E Hersh;LE Flaherty;VK Sondak
Journal / Conference
Proc of the American Society of Clinical Oncology 21:347a(#1386)
Year
2002
Research Committee(s)
Melanoma
Study Number(s)
S9804

Southwest Oncology Group Trial (SWOG) 9914: phase II trial of paclitaxel, carboplatin and topotecan (PCT) in untreated patients (pts) with extensive small cell lung cancer (SCLC).

Authors
F Dunphy;P Hesketh;K Chansky;DR Gandara
Journal / Conference
Proc of the American Society of Clinical Oncology 21:297a(#1184)
Year
2002
Research Committee(s)
Lung
Study Number(s)
S9914

A phase II study of farnesyl transferase inhibitor R115777 in pancreatic cancer. a Southwest Oncology Group (SWOG) study.

Authors
J Macdonald;K Chansky;R Whitehead;J Wade;J Giguere;J Abbruzzese
Journal / Conference
Proc of the American Society of Clinical Oncology 21:138a(#548)
Year
2002
Research Committee(s)
Gastrointestinal
Study Number(s)
S9924

SWOG 0004: pilot study of tirapazamine (TPZ) plus cisplatin/etoposide (PE) and concurrent thoracic radiotherapy (RT) in limited small cell lung cancer (LSCLC).

Authors
QT Le;K Chansky;S Williamson;M Edelman;J Ryu;LE Gaspar;J Crowley;DR Gandara
Journal / Conference
Proc of the American Society of Clinical Oncology 21:294a(#1174)
Year
2002
Research Committee(s)
Lung
Study Number(s)
S0004

Phase III dose-randomized study of Imatinib mesylate (Gleevec, STI571) for GIST: Intergroup S0033 early results

Authors
GD Demetri;C Rankin;C Fletcher;R Benjamin;C Blanke;M Von Mehren;V Bramwell;R Maki;R Blum;K Antman;L Baker;E Borden
Journal / Conference
Proc of the American Society of Clinical Oncology 21:413a(#1651)
Year
2002
Research Committee(s)
Sarcoma
Study Number(s)
S0033

Ten-year survival in patients with metastatic (M+) prostate cancer (CAP): analysis of Southwest Oncology Group (SWOG) 8894.

Authors
ED Crawford;J Faulkner;IM Thompson;M Eisenberger;C Tangen;M Hussain
Journal / Conference
Journal of Urology 167(4)Suppl:304(#1202)
Year
2002
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8894 (INT-0105) (EST-2889)

Risk assessment in localized primary cutaneous melanoma: a Southwest Oncology Group study evaluating nine factors and a test of the Clark logistic regression prediction model.

Authors
RJ Tuthill;JM Unger;PY Liu;LE Flaherty;VK Sondak
Journal / Conference
American Journal of Clinical Pathology 118(4):504-511
Year
2002
Research Committee(s)
Melanoma
Study Number(s)
SWOG-8049

Outcome after induction chemotherapy for older patients with acute myeloid leukemia is not improved with mitoxantrone and etoposide compared to cytarabine and daunorubicin: a Southwest Oncology Group study

Authors
JE Anderson;KJ Kopecky;CL Willman;D Head;MR O'Donnell;FW Luthardt;TH Norwood;IM Chen;SP Balcerzak;DB Johnson;FR Appelbaum
Journal / Conference
Blood 100(12):3869-3876
Year
2002
Research Committee(s)
Leukemia
Study Number(s)
SWOG-9333